Skip to main content Skip to secondary navigation

Docket #: S09-309

Using Minicircle DNAs to Generate Viral-Free Induced Pluripotent Cells

A team of Stanford researchers have developed a simple, novel, non-viral technique for generating human induced pluripotent stem cells (hiPSCs) with minicircle DNA. This technology uses a single minicircle vector that expresses four reprogramming factors. Because the vector is non-viral, there is no risk of genomic insertional mutagenesis. Furthermore, unlike other non-viral or protein-based methods, minicircles can be used with limited molecular biology expertise. Compared to plasmids, minicircle DNA has higher transfection efficiencies and longer expression. These vectors have broad applications for reprogramming cells to be used in regenerative medicine and research.

Stage of Research
The inventors have used the minicircles to reprogram human adipose stem cells (hASCs) into human induced pluripotent stem cells (hiPSCs). The advantages of using hASCs for generating hiPSCs are further described in Stanford Docket S08-438.

Applications

  • Regenerative medicine
  • Research

Advantages

  • Safe - non-viral approach results in hiPSCs without genomic insertions
  • Fast - reprogramming process is ~18 days
  • Simple techniques - limited molecular biology needed, no vector excision or drug selection
  • Efficient - 10 fold increase compared to reprogramming fibroblasts using plasmids

Publications

Patents

Similar Technologies

Explore similar technologies by keyword: